News

Don't let anyone tell you that mid-October is boring. Amazon (NASDAQ: AMZN), Walmart (NYSE: WMT), Target (NYSE: TGT), Best Buy (NYSE: BBY), and Apple (NASDAQ: AAPL) all have big events lined up for

It seems fair to say at this point that the upcoming election is a bit divisive. When looking at stocks, it's helpful to put political persuasions aside and seek out companies that won't get drawn

Airline stocks in recent weeks have been flying through turbulence, caught up in an election-year battle in Washington over a second stimulus bill. The industry has been hit hard by the COVID-19

Luxury jewelry maker Tiffany & Co. has never held a sale in its corporate history. Demand for the company's premium wares and the iconic little blue box has been enough to maintain high prices --

If you're ignoring dividend-paying stocks in your investing, you're doing your portfolio a big disservice. Consider, for example, a 2013 J.P. Morgan Asset Management report that looked at companies

Testing is a major part of conquering the coronavirus crisis. If governments test as many people as possible, those who are sick or carry the virus can self-quarantine, which prevents further spread

Inovio Pharmaceuticals (NASDAQ: INO) seemed like it could make millionaires out of many average investors -- and fast -- earlier this year. The clinical-stage biotech company soared 718% from the

In the bizarre market conditions of 2020, it's become even more evident that Robinhood traders are a cryptic and powerful force. Between their inscrutable support of bankrupt companies and wild

The 2020 news cycle has been dominated by the coronavirus -- and understandably so. There have been over 36 million confirmed cases and 1 million deaths related to the virus worldwide. Economic and

Warren Buffett is one of the most well-known investors of our time, so it pays to heed his advice. And if there's one investment he's a big fan of, it's index funds.

To be fair, Buffett has made

Problems abound for popular pot stock Aurora Cannabis (NYSE: ACB). Poor financial results, an ugly balance sheet, and share dilution problems have chased investors away in 2020. Consequently, Aurora

Of far more importance than a stock's valuation is the business's current size relative to its future potential. And with the COVID-19 pandemic reshaping the economy, lots of smaller companies could

As the coronavirus pandemic has progressed, healthcare companies engaged in the development and manufacturing of COVID-19 vaccines and therapeutics have become the darlings of the stock market

This year has exposed investors to some of the wildest volatility on record. The unprecedented uncertainty created by the coronavirus pandemic caused the benchmark S&P 500 (SNPINDEX: ^GSPC) to lose

When most of us think of coronavirus stocks, we think of vaccine makers or drug treatment companies. A heart-pump specialist doesn't first come to mind. That's why this company wasn't among the most

There's been a lot of focus on clinical stage biotech companies and the coronavirus vaccine race over the past few months. But President Donald Trump's recent COVID-19 diagnosis has thrown one

When it comes to socking money away for retirement, a 401(k) plan isn't your only option -- but it's a worthwhile savings tool to look at. In fact, the more you learn about 401(k)s, the more

Two very different drugmakers have recently joined the elite group of companies with coronavirus vaccines in late-stage testing. Johnson & Johnson (NYSE: JNJ) initiated a global phase 3 clinical

Social Security is second to none in terms of importance. According to the Social Security Administration, more than 3 in 5 seniors leans on their payouts to account for at least half of their

In most investment portfolios, a small number of winning stocks usually account for an outsize share of the overall returns. To get the most out of those winners, investors must resist the urge to

When the curtain finally closes on 2020, it'll likely go down as one of the most volatile years in history. The widely followed S&P 500 declined by 34% in under five weeks during the first quarter

AstraZeneca (NYSE: AZN) has secured $486 million from the U.S. government's Biomedical Advanced Research and Development Authority to support the development of AZD7442, an antibody cocktail for the

Shares of Peloton Interactive (NASDAQ: PTON) rose 7% to a new closing high of $123.02 on Friday, as investors continue to pile into the home-based fitness leader's stock. 

Analysts have anointed

Shares of GameStop (NYSE: GME) declined by 11% on Friday, as the video game retailer gave back a good chunk of its recent gains. 

GameStop soared a staggering 44% on Thursday after it announced a

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Jim Gillies about the latest headlines and earning reports from Wall Street. They look at the latest earning report of a